Literature DB >> 22706685

Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions.

Conceição Bettencourt1, Mafalda Raposo, Raquel Ros, Rafael Montiel, Jácome Bruges-Armas, Manuela Lima.   

Abstract

Alternative splicing (AS) of pre-mRNA is an important regulatory mechanism that enables one gene to produce multiple mature transcripts and, therefore, multiple protein isoforms. Besides the information content of core splicing signals, additional cis-regulatory elements (splicing enhancers and silencers) are needed to precisely define exons. AS is well documented in ATXN3 gene, which encodes for ataxin-3 and, when mutated, is responsible for Machado-Joseph disease (MJD). By studying MJD patients and controls, we have previously identified 56 alternative transcript variants for this gene; some were predicted to encode "protective" ataxin-3 isoforms, making then pertinent to understand AS regulation. The present study aims to investigate the relationship between variation in ATXN3 cis-regulatory motifs and AS variants found for each individual. We have sequenced exonic and flanking intronic ATXN3 regions, in genomic DNA from MJD patients and controls previously studied. None of the 10 single nucleotide polymorphisms (SNPs) that were found was located in core splicing signals. In silico analysis showed those SNPs implied losses and gains of recognition motifs for splicing factors. Each particular allele was not directly reflected in alterations of the resulting splicing variants, indicating that AS cannot be determined solely by these cis-elements, but should result from a more complex mode of regulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706685     DOI: 10.1007/s12031-012-9832-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  15 in total

1.  RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression.

Authors:  Emilie Lalonde; Kevin C H Ha; Zibo Wang; Amandine Bemmo; Claudia L Kleinman; Tony Kwan; Tomi Pastinen; Jacek Majewski
Journal:  Genome Res       Date:  2010-12-20       Impact factor: 9.043

Review 2.  Neuronal regulation of alternative pre-mRNA splicing.

Authors:  Qin Li; Ji-Ann Lee; Douglas L Black
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

Review 3.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

4.  The APOE ε2 allele increases the risk of earlier age at onset in Machado-Joseph disease.

Authors:  Conceição Bettencourt; Mafalda Raposo; Nadiya Kazachkova; Teresa Cymbron; Cristina Santos; Teresa Kay; João Vasconcelos; Patrícia Maciel; Karina C Donis; Maria Luiza Saraiva-Pereira; Laura B Jardim; Jorge Sequeiros; Manuela Lima
Journal:  Arch Neurol       Date:  2011-12

Review 5.  RNA-targeted splice-correction therapy for neuromuscular disease.

Authors:  Matthew J A Wood; Michael J Gait; Haifang Yin
Journal:  Brain       Date:  2010-02-11       Impact factor: 13.501

6.  The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.

Authors:  Conceição Bettencourt; Cristina Santos; Rafael Montiel; Teresa Kay; João Vasconcelos; Patrícia Maciel; Manuela Lima
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

7.  Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).

Authors:  Conceição Bettencourt; Cristina Santos; Rafael Montiel; Maria do Carmo Costa; Pablo Cruz-Morales; Liliana Ribeiro Santos; Nelson Simões; Teresa Kay; João Vasconcelos; Patrícia Maciel; Manuela Lima
Journal:  Neurogenetics       Date:  2009-08-28       Impact factor: 2.660

8.  Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition.

Authors:  Yang Yu; Patricia A Maroney; John A Denker; Xiang H-F Zhang; Olexandr Dybkov; Reinhard Lührmann; Eckhard Jankowsky; Lawrence A Chasin; Timothy W Nilsen
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

9.  Alternative splicing: regulation without regulators.

Authors:  Brenton R Graveley
Journal:  Nat Struct Mol Biol       Date:  2009-01       Impact factor: 15.369

10.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

View more
  2 in total

1.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

2.  Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.

Authors:  Lodewijk J A Toonen; Frank Rigo; Haico van Attikum; Willeke M C van Roon-Mom
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-29       Impact factor: 8.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.